The classical clinical presentations of patients with neurosyphilis is now a rarity in developed countries. ' The widespread use ofantibiotics and corticosteroids for treating conditions unrelated to syphilis may be responsible for "modified" neurosyphilis as sometimes seen nowadays.' 2 In most of these "modified" cases there appears to be no single or combined clinical or laboratory method which can establish with certainty a diagnosis of active neurosyphilis. 3 Reports have revealed that screening tests for syphilis on cerebro-spinal fluid (CSF) have been performed on clinical grounds, sometimes without prior blood screening, although, a negative serum Treponema Pallidum Haemagglutination Assay (TPHA) virtually excludes active neurosyphilis. 4 Lumbar puncture, however, is considered essential in syphilis of uncertain duration, in late symptomatic or late latent stages and in clinical relapse or a fourfold rise in serological titres following treatment. 5 Although lumbar puncture may be relatively safe, group of 12 patients with abnormalities, one had had a cerebrovascular accident, one suffered from deafness, six had pupillary changes, one had blackouts and dizzy spells, one had extensor-plantar reflexes and there were two with tabes dorsalis.
The figure shows the serum TPHA titres for 258 patients, two of the previously diagnosed neurosyphilis patients not having titres recorded at the time of the original diagnosis and so they are not represen- The value of serum TPHA titres in selecting patients for lumbar puncture Table 2 shows that eight of the nine (the other result not being available) previously diagnosed cases of neurosyphilis, had abnormal CSF protein (> 0 5 g/l) at the time of the original diagnosis and two also had abnormal CSF white blood cell counts. Where the test was available, the patients were also all CSF-FTA positive.
In Table 3 All nineteen patients in whom serum TPHA titres had been reported at the time of their initial test (two of the previously diagnosed cases of neurosyphilis did not have titres recorded initially but did have subsequent titres of 1:5120) had levels of 1:2560 or greater. If therefore a serum titre of 1:2560 had been taken as a cut-off point for performing a lumbar puncture on the 249 patients (excluding those with known neurosyphilis) in the study only 59 would have been undertaken, thereby reducing the incidence of lumbar puncture by 76.3%. Even if a titre of 1:1280 was taken as the cut-off level to allow for a safety margin, the total number of lumbar punctures would have been only 81, still producing a substantial reduction (by 68%) in the overall numbers. Apart from eliminating any potential risk to the patients there would have been a substantial financial saving-a study from the USA calculated the cost of performing a lumbar puncture to be in the region of 600 dollars. 7 We acknowledge that our population in this survey was predominantly non-caucasian and so a percentage possibly had yaws and not syphilis, since there is no distinguishing serological tests to differentiate between these two conditions. However, syphilis is certainly not a rarity in the Caribbean and the Indian sub-continent, and so unless one can We emphasise that the aim ofthis study was not the diagnosis of neurosyphilis (especially since we did not have access in these patients to other CSF parameters such as CSF immunoglobulins which are nowadays considered very useful in the diagnosis of neurosyphilis),'4 but to search for a simple criterion which could justify the performance of a lumbar puncture in asymptomatic patients. We conclude from our study that a serum TPHA titre of 1:2560 or above should be considered as a criterion for performing lumbar puncture on the asymptomatic patient with late syphilis (more than two years duration). Finally, since patients with both syphilis and human immunodeficiency virus (HIV) infection presents a far more complex subject,'5 we feel more study is required in this group before we could advocate our above criterion for performing lumbar punctures. 
